COVID-19 Immune Repertoire Sequencing (IMSEQ)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Koen Vercauteren
- Phone Number: +32 3 247 63 32
- Email: kvercauteren@itg.be
Study Locations
-
-
-
Antwerp, Belgium
- Universitairy hospital of Antwerp
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- laboratory confirmed COVID-19 acute infection
- be older than 18 years of age
- be hospitalized at the UZA
- willing and able to provide written informed consent by the participant or its legal representative (for instance in case of medical incapacitation)
Exclusion Criteria:
- younger than 18 years old
- Ambulatory patients
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
provide proof-of-concept that (longitudinal) B cell repertoire mining allows identification of emerging virus specific B cell receptor variable regions.
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
study evolutions in B and T cell repertoires to understand COVID-19 specific immune responses fundamentally.
Time Frame: every 7 days during hospitalization a bloodsample is taken
|
every 7 days during hospitalization a bloodsample is taken
|
|
clinical and epidemiological description of UZA hospitalized COVID-19 patients
Time Frame: at hospitalization
|
at hospitalization
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IMSEQ
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.